Litcius/Paper detail

Treatment of erythema migrans with doxycycline for 7 days versus 14 days in Slovenia: a randomised open-label non-inferiority trial

Daša Stupica, Stefan Collinet‐Adler, Rok Blagus, Anja Gomišček, Tjaša Cerar, Eva Ružić‐Sabljić, Maša Velušček

2022The Lancet Infectious Diseases28 citationsDOI

Topics & Concepts

DoxycyclineErythema migransOpen labelMedicineDermatologyErythemaErythema chronicum migransSurgeryRandomized controlled trialBorrelia burgdorferiAntibioticsBiologyImmunologyMicrobiologyLyme borreliosisAntibodyVector-borne infectious diseasesMalaria Research and ControlMosquito-borne diseases and control
Treatment of erythema migrans with doxycycline for 7 days versus 14 days in Slovenia: a randomised open-label non-inferiority trial | Litcius